Point Biopharma shares sink after pricing new stock offering at discount
Indianapolis-based biotech firm Point Biopharma Global Inc. hopes to raise about $125 million in the offering, before underwriting expenses and deductions.
Pharmaceutical
Articles
Italian manufacturer expands plan for Fishers by $367M, 265 workers
City officials said Stevanato Group wants to increase its total investment in its Fishers plant to $512 million and its hiring plan to 515 employees. The facility is under construction near 126th Street and Cumberland Road.
FDA panel backs much-debated ALS drug in rare, second review
The ruling Wednesday was a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year.
FDA chief says long-awaited opioid review still in works
A review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency’s commissioner said Tuesday.
Insulin cap for Medicare patients signals hope for others
In January, the cost of insulin for patients on Medicare will be capped at $35 a month. But that cap doesn’t apply to those with private insurance, which is used by the majority of those in need of insulin.
Study: Pfizer COVID pill showed no benefit in younger adults
The researchers found that Paxlovid reduced hospitalizations among people 65 and older by roughly 75% when given shortly after infection. But people between the ages of 40 and 65 saw no measurable benefit, according to the analysis of medical records.
AstraZeneca CEO warns U.S. pricing rules will delay new drugs
U.S. legislation requiring price negotiation for top-selling medicines will delay the launch of new drugs, AstraZeneca CEO Pascal Soriot warned.
Pfizer buying spree continues with $5.4B hematology deal
The pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. The drugmaker has announced deals valued at a total of nearly $19 billion, counting debt, since late last year.
Jury orders Lilly to pay $61M in whistleblower Medicaid fraud case
The cost to Indianapolis-based Eli Lilly and Co. would reach more than $183 million because cases brought under the False Claims Act triple the final judgment. Lilly said it plans to appeal and is confident that it will prevail.
Lilly Q2 profit slumps 33% as older products lose steam
Indianapolis-based Eli Lilly and Co. posted a profit of $1.13 billion, down from $1.68 billion a year ago, and cut its full-year profit guidance.
Inotiv says closures of animal-breeding facilities could cost it nearly $10M
Indiana-based pharmaceutical testing company Inotiv Inc. disclosed late Monday that it expects to incur charges of between $7.4 million and $9.9 million for the previously announced shutdowns of two Virginia animal-breeding facilities.
Inotiv subsidiary reaches settlement in animal welfare lawsuit
As part of the settlement, Indianapolis-based Envigo will relinquish 4,000 beagles at a dog-breeding facility to the Humane Society of the United States, or HSUS.
Lilly overtakes larger rival Pfizer in market cap as shares continue to soar
Like a kite that has caught a stiff breeze, Eli Lilly and Co. stock is having the ride of its life. Shares in the Indianapolis-based drugmaker have soared 41% in the past 52 weeks, to about $331 each.
Drugmaker seeks FDA approval for over-the-counter birth control
For the first time, a pharmaceutical company has asked for permission to sell a birth control pill over the counter in the United States.
Inotiv facing shareholder lawsuit over stock drop
The West Lafayette-based pharmaceutical testing company has seen its stock price soar—and later plunge—following its announcement last fall that it planned to acquire Indianapolis-based Envigo RMS LLC, which breeds and sells animals used in lab testing.
Q&A with Cathy Langham about growing cold-storage demand
Indianapolis-based Langham Logistics is set to open a 150,000-square-foot warehouse in Whitestown to serve pharmaceutical and biotech companies—and their suppliers—who need cold storage, meaning anything from chilled space to ultra-low-temperature freezers.
FDA authorizes first COVID-19 shots for infants, preschoolers
The FDA also authorized Moderna’s vaccine for school-aged children and teens. Pfizer’s shots had been the only option for those ages.
FDA advisers endorse first COVID-19 shots for children under 5
An advisory panel for the Food and Drug Administration gave a thumbs-up Wednesday to vaccines from Moderna and Pfizer for children under 5. It’s the only age group not yet eligible for vaccination against the coronavirus.
Lilly whistleblower sues drugmaker, alleging retaliation
A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matter.
Small cancer drug trial sees tumors disappear in 100% of patients
Researchers in the field of colorectal cancer are hailing the study, published Sunday in the New England Journal of Medicine, as a groundbreaking development that could lead to new treatments for other cancers as well.